erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

References related to abnormalities published in Antimicrob. Agents Chemother.

PMID	Journal	Published Date	Author	Title
9527789	Antimicrob. Agents Chemother.	1998	den Hollander JG et al.	Comparison of pharmacodynamics of azithromycin and erythromycin in vitro and in vivo.
9559823	Antimicrob. Agents Chemother.	1998	Hoppe JE and Bryskier A	In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine).
9624507	Antimicrob. Agents Chemother.	1998	Roblin PM and Hammerschlag MR	In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.
10428903	Antimicrob. Agents Chemother.	1999	Johnson MM et al.	Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents.
9835514	Antimicrob. Agents Chemother.	1998	Berry V et al.	Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae.
11502536	Antimicrob. Agents Chemother.	2001	Kenny GE and Cartwright FD	Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones.
11408246	Antimicrob. Agents Chemother.	2001	Nilius AM et al.	Comparative in vitro activity of ABT-773, a novel antibacterial ketolide.
12183262	Antimicrob. Agents Chemother.	2002	Ng LK et al.	Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae.
12183270	Antimicrob. Agents Chemother.	2002	Prunier AL et al.	Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides.
12821495	Antimicrob. Agents Chemother.	2003	Bingen E et al.	Activity of telithromycin against penicillin-resistant Streptococcus pneumoniae isolates recovered from French children with invasive and noninvasive infections.
10639346	Antimicrob. Agents Chemother.	2000	Gisby J and Bryant J	Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.
10991883	Antimicrob. Agents Chemother.	2000	Cynamon MH et al.	Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.
10858333	Antimicrob. Agents Chemother.	2000	Plouffe J et al.	Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials Group.
10722500	Antimicrob. Agents Chemother.	2000	Brophy DF et al.	Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers.
9797240	Antimicrob. Agents Chemother.	1998	Piccolomini R et al.	Bacteriostatic and bactericidal in vitro activities of clarithromycin and erythromycin against periodontopathic Actinobacillus actinomycetemcomitans.
10103198	Antimicrob. Agents Chemother.	1999	Kohyama T et al.	Fourteen-member macrolides inhibit interleukin-8 release by human eosinophils from atopic donors.
11600391	Antimicrob. Agents Chemother.	2001	Nagai K et al.	Activities of a new fluoroketolide, HMR 3787, and its (des)-fluor derivative RU 64399 compared to those of telithromycin, erythromycin A, azithromycin, clarithromycin, and clindamycin against macrolide-susceptible or -resistant Streptococcus pneumoniae and S. pyogenes.
21628536	Antimicrob. Agents Chemother.	2011	Wingard JB et al.	A novel cell-associated protection assay demonstrates the ability of certain antibiotics to protect ocular surface cell lines from subsequent clinical Staphylococcus aureus challenge.
20855744	Antimicrob. Agents Chemother.	2010	Donati M et al.	In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K.
19273669	Antimicrob. Agents Chemother.	2009	Beeton ML et al.	Concurrent titration and determination of antibiotic resistance in ureaplasma species with identification of novel point mutations in genes associated with resistance.
19171799	Antimicrob. Agents Chemother.	2009	Nash KA et al.	A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae.
20404127	Antimicrob. Agents Chemother.	2010	Grinwis ME et al.	Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients.
20625152	Antimicrob. Agents Chemother.	2010	Biedenbach DJ et al.	Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection.
20585125	Antimicrob. Agents Chemother.	2010	Chisholm SA et al.	High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes.
20498312	Antimicrob. Agents Chemother.	2010	Gunell M et al.	In vitro activity of azithromycin against nontyphoidal Salmonella enterica.
20176910	Antimicrob. Agents Chemother.	2010	Woosley LN et al.	CEM-101 activity against Gram-positive organisms.
21911560	Antimicrob. Agents Chemother.	2011	Maezono H et al.	Antibiofilm effects of azithromycin and erythromycin on Porphyromonas gingivalis.
17908942	Antimicrob. Agents Chemother.	2007	Binet R and Maurelli AT	Frequency of development and associated physiological cost of azithromycin resistance in Chlamydia psittaci 6BC and C. trachomatis L2.
17954687	Antimicrob. Agents Chemother.	2008	Starner TD et al.	Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms.
17606685	Antimicrob. Agents Chemother.	2007	Gibreel A et al.	Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni.
15793125	Antimicrob. Agents Chemother.	2005	Falzari K et al.	In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.
16251306	Antimicrob. Agents Chemother.	2005	Wierzbowski AK et al.	Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides.
15504828	Antimicrob. Agents Chemother.	2004	Matic V et al.	Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
15504829	Antimicrob. Agents Chemother.	2004	Kosowska K et al.	Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.
23208707	Antimicrob. Agents Chemother.	2013	Goodman CD et al.	Chemobiosynthesis of new antimalarial macrolides.